Semglee has been approved for over a ... materials for health care providers to help them learn about interchangeable biosimilars. Lantus – said to be the most administered basal insulin across ...

More than a year ago, Adam Fein predicted this would happen when he discussed the launch of long-acting Semglee (insulin glargine ... reference product – Lantus - and the lower-priced biosimilar.